# 2020-2022 Biomedical Engineering Society (BMES) Cellular and Molecular (CMBE) Conference

> **NIH NIH R13** · BIOMEDICAL ENGINEERING SOCIETY · 2022 · $13,000

## Abstract

Abstract
 The goal of this application is to support travel awards for students, fellows, and early stage investigators
(ESI) to attend the Cellular and Molecular Bioengineering (CMBE) Conference. The specific theme of the
2020 conference will be ‘Vision 2020: Emerging Technologies to Elucidate the Rules of Life. The choice of
theme is intended to address the key problem of how the new emerging technologies can help us to
engineer better biological systems to transform our understanding of rule of life, as well as translate
new discoveries in ways that ultimately benefit human health. Recently, many new technologies have
been developed such as genomic/epigenetic editing, single cell to tissue-level cell atlas, tools to manipulate
extracellular environment, and methods to fabricate cell/tissue structure in 3D. Within this central theme, a
broad spectrum of isolated groups has emerged from disparate disciplines but has not been fully engaged in
the CMBE community. The need for this conference lies in the unique opportunity to bring these investigators
together in one room for the first time to exchange ideas and brainstorm new combined strategies for pushing
the field of molecular and cellular engineering forward to a new level of integration. The outcome of the
conference will be increased technology sharing amongst researchers, as well as a new vision and strategic
plan for engineering biological systems for basic science and clinical translation.
 The specific objectives of this R13 application are two-fold. The first is to provide support to eight ESI
junior investigators and twelve postdoctoral fellows or graduate students, whose submitted papers will
be selected for podium presentation on the basis of scientific merit, with a focus on promoting women and
underrepresented minorities. The meeting will provide these investigators with essential exposure and
mentoring to launch or expand their academic research careers. The second objective is to foster adoption of
new technologies to the CMBE research community and promote the interdisciplinary collaboration.
The meeting will provide a platform to expose researchers in engineering, chemistry, biology, and data science
to the latest techniques and develop a pathway to increase the impact of CMBE research in human disease.
Aim #1: Present transformative CMBE discoveries and techniques to a diverse engineering and biology
audience. Invited speakers will discuss their latest research during their presentations, with a special emphasis
on new principles or rules in engineering biological systems.
Aim #2: Outline potential pathways to translate fundamental CMBE research into diagnostics and therapies in
human disease. This will provide guidelines in how to connect researchers, and in fact the entire CMBE field,
with clinicians and industry to increase translation of this research area.
 Outcomes will be published in a special issue of the BMES Cellular and Molecular Bioengineering Journal.

## Key facts

- **NIH application ID:** 10076828
- **Project number:** 5R13EB029293-02
- **Recipient organization:** BIOMEDICAL ENGINEERING SOCIETY
- **Principal Investigator:** Brenton D Hoffman
- **Activity code:** R13 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $13,000
- **Award type:** 5
- **Project period:** 2019-12-24 → 2023-12-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10076828

## Citation

> US National Institutes of Health, RePORTER application 10076828, 2020-2022 Biomedical Engineering Society (BMES) Cellular and Molecular (CMBE) Conference (5R13EB029293-02). Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/grant/nih/10076828. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
